CNS remyelination as a novel reparative approach to neurodegenerative diseases: The roles of purinergic signaling and the P2Y-like receptor GPR17

CNS remyelination as a novel reparative approach to neurodegenerative diseases: The roles of purinergic signaling and the P2Y-like receptor GPR17

Item
http://www.wikidata.org/entity/Q28268336
Cysteinyl Leukotrienes and Their Receptors: Emerging Therapeutic Targets in Central Nervous System DisordersThe G Protein-Coupled Receptor GPR17: Overview and Update.Expression of GPR17, a regulator of oligodendrocyte differentiation and maturation, in Nasu-Hakola disease brains.Pharmacological Properties and Biological Functions of the GPR17 Receptor, a Potential Target for Neuro-Regenerative Medicine.Cysteinyl Leukotrienes as Potential Pharmacological Targets for Cerebral Diseases.Extracellular cues influencing oligodendrocyte differentiation and (re)myelinationA human brain microphysiological system derived from induced pluripotent stem cells to study neurological diseases and toxicity.Intertwining extracellular nucleotides and their receptors with Ca2+ in determining adult neural stem cell survival, proliferation and final fate.Regulation of adult neural progenitor cell functions by purinergic signaling.Neuro-psychopharmacological perspective of Orphan receptors of Rhodopsin (class A) family of G protein-coupled receptors.Purinergic Signalling: Therapeutic Developments.Erythropoietin Increases Myelination in Oligodendrocytes: Gene Expression Profiling Reveals Early Induction of Genes Involved in Lipid Transport and Metabolism.Pathophysiological Role of Purines and Pyrimidines in Neurodevelopment: Unveiling New Pharmacological Approaches to Congenital Brain Diseases.Differential local tissue permissiveness influences the final fate of GPR17-expressing oligodendrocyte precursors in two distinct models of demyelination.GPR17 mediates ischemia-like neuronal injury via microglial activationThe Impact of Purinergic System Enzymes on Noncommunicable, Neurological, and Degenerative Diseases
P2860

CNS remyelination as a novel reparative approach to neurodegenerative diseases: The roles of purinergic signaling and the P2Y-like receptor GPR17

Item
http://www.wikidata.org/entity/Q28268336
description
2016 nî lūn-bûn
@nan
2016 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
CNS remyelination as a novel r ...... nd the P2Y-like receptor GPR17
@ast
CNS remyelination as a novel r ...... nd the P2Y-like receptor GPR17
@en
CNS remyelination as a novel r ...... nd the P2Y-like receptor GPR17
@nl
type
label
CNS remyelination as a novel r ...... nd the P2Y-like receptor GPR17
@ast
CNS remyelination as a novel r ...... nd the P2Y-like receptor GPR17
@en
CNS remyelination as a novel r ...... nd the P2Y-like receptor GPR17
@nl
prefLabel
CNS remyelination as a novel r ...... nd the P2Y-like receptor GPR17
@ast
CNS remyelination as a novel r ...... nd the P2Y-like receptor GPR17
@en
CNS remyelination as a novel r ...... nd the P2Y-like receptor GPR17
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P478
P50
P577
P698
P921
P356
P1433
P1476
CNS remyelination as a novel r ...... nd the P2Y-like receptor GPR17
@en
P2093
P304
P31
P356
10.1016/J.NEUROPHARM.2015.10.005
P407
P478
P50
P577
P698
P921